12 results · 27ms · Sources: EU EUDAMED, US FDA

Get notified when this changes

We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.

MENISCAL CINCH

FDA 510(k)
FDA Class 2 ·General, Plastic Surgery

NOBELREPLACE CC PMC RP 4.3X10MM

FDA Adverse Event
Injury ·NOBEL BIOCARE USA INC·Product code DZE·June 15, 2021

NOBELPARALLEL CC NP 3.75X13MM

FDA Adverse Event
Injury ·NOBEL BIOCARE AB·Product code DZE·March 8, 2021

NOBELPARALLEL CC NP 3.75X13MM

FDA Adverse Event
Injury ·NOBEL BIOCARE AB·Product code DZE·March 8, 2021

FIRSTLINE BRAND DOUBLE POLYMER COATED NITRILE EXAMINATION GLOVES (POWDER FREE-STEEL BLUE COLOR)

FDA 510(k)
FDA Class 1 ·General Hospital

ULTIMATE PROFESSIONAL CONTINUOUS FLOW COLONIC SYSTEM

FDA 510(k)
FDA Class 2 ·Gastroenterology, Urology

LAVA C.O.S. POWDER

FDA Adverse Event
Injury ·3M ESPE DENTAL PRODUCTS·Product code NOF·March 16, 2012

ARCHITECT HAVAB-G

FDA Adverse Event
Malfunction ·ABBOTT GERMANY·Product code LOL·April 23, 2013

M SERIES

FDA Adverse Event
Malfunction ·ZOLL MEDICAL CORPORATION·Product code MKJ·March 25, 2011

DURATA STS OPTIM ACTIVE FIXATION

FDA Adverse Event
Injury ·ST JUDE MEDICAL CARDIAC RHYTHM MANAGEMENT DIVISION·Product code LWS·July 11, 2008

Stryker MA204 Bed Model (FL25E) Beds are intended for medical purposes in both general patient care as well as critical care environments. Each uses built-in electric motors and controls which can be operated by the patient, or caregiver, to adjust the height and/or surface contour of the bed.The devices listed above also include movable and latchable side rails which can be lowered or raised to help prevent patient fall and subsequent injury. The Beds include an optional Scale (Models: FL20E, FL25E, FL28C, FL28EX) as well as an optional Bed Exit (1 Zone) or Chaperone

FDA Enforcement
Class II ·Terminated·Stryker Medical Division of Stryker Corporation·July 4, 2012

CADD-Solis VIP ambulatory Infusion Pumps, Model 2110. Indicated for the following uses: Intra-arterial, subcutaneous, intraperitoneal, in close proximity to nerves, into an intraoperative site, epidural space or subarachnoid space. Therapies that require a continuous rate of infusion, intermittent bolus, and/or with patient-controlled demand doses.

FDA Enforcement
Class I ·Ongoing·Smiths Medical ASD Inc.·August 14, 2024